Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutr Rev ; 61(1): 1-33, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12638461

RESUMEN

Soy isoflavones have been a component of the diet of certain populations for centuries. The consumption of soy generally has been considered beneficial, with a potentially protective effect against a number of chronic diseases; because of their estrogenic activity, however, negative effects of isoflavones have been postulated. This review examines the literature associated with the safety of soy isoflavones, including dietary soy isoflavone exposure data of populations with high soy intakes, human studies in which soy protein or isoflavones were provided, and toxicologic studies investigating the potential genotoxicity, carcinogenicity, and reproductive and developmental toxicity of soy isoflavones. Whereas results in some studies are limited or conflicting, when viewed in its entirety, the current literature supports the safety of isoflavones as typically consumed in diets based on soy or containing soy products.


Asunto(s)
Seguridad de Productos para el Consumidor , Glycine max , Isoflavonas , Proteínas de Soja , Animales , Enfermedad Crónica , Estrógenos no Esteroides/administración & dosificación , Estrógenos no Esteroides/efectos adversos , Femenino , Humanos , Isoflavonas/administración & dosificación , Isoflavonas/efectos adversos , Isoflavonas/uso terapéutico , Masculino , Fitoestrógenos , Preparaciones de Plantas , Proteínas de Soja/administración & dosificación , Proteínas de Soja/efectos adversos , Glycine max/efectos adversos
2.
Regul Toxicol Pharmacol ; 35(2 Pt 2): S1-93, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12180494

RESUMEN

Over 20 years have elapsed since aspartame was approved by regulatory agencies as a sweetener and flavor enhancer. The safety of aspartame and its metabolic constituents was established through extensive toxicology studies in laboratory animals, using much greater doses than people could possibly consume. Its safety was further confirmed through studies in several human subpopulations, including healthy infants, children, adolescents, and adults; obese individuals; diabetics; lactating women; and individuals heterozygous (PKUH) for the genetic disease phenylketonuria (PKU) who have a decreased ability to metabolize the essential amino acid, phenylalanine. Several scientific issues continued to be raised after approval, largely as a concern for theoretical toxicity from its metabolic components--the amino acids, aspartate and phenylalanine, and methanol--even though dietary exposure to these components is much greater than from aspartame. Nonetheless, additional research, including evaluations of possible associations between aspartame and headaches, seizures, behavior, cognition, and mood as well as allergic-type reactions and use by potentially sensitive subpopulations, has continued after approval. These findings are reviewed here. The safety testing of aspartame has gone well beyond that required to evaluate the safety of a food additive. When all the research on aspartame, including evaluations in both the premarketing and postmarketing periods, is examined as a whole, it is clear that aspartame is safe, and there are no unresolved questions regarding its safety under conditions of intended use.


Asunto(s)
Aspartame/efectos adversos , Edulcorantes/efectos adversos , Afecto/efectos de los fármacos , Animales , Aspartame/administración & dosificación , Aspartame/metabolismo , Aspartame/toxicidad , Conducta/efectos de los fármacos , Neoplasias Encefálicas/inducido químicamente , Cognición/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Hipersensibilidad a las Drogas/etiología , Electroencefalografía/efectos de los fármacos , Sistema Endocrino/efectos de los fármacos , Cefalea/inducido químicamente , Humanos , Metanol/metabolismo , Fenilalanina/metabolismo , Vigilancia de Productos Comercializados , Convulsiones/inducido químicamente , Edulcorantes/administración & dosificación , Edulcorantes/metabolismo , Edulcorantes/toxicidad , Pérdida de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA